SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000927016-02-002392
Filing Date
2002-04-30
Accepted
2002-04-30 12:33:22
Documents
1
Period of Report
2002-06-25

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT ddef14a.txt DEF 14A 78597
  Complete submission text file 0000927016-02-002392.txt   80153
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 000-10824 | Film No.: 02626314
SIC: 2835 In Vitro & In Vivo Diagnostic Substances